logo
Ishiba pens letter to Xi as Japan aims to avoid trade crossfire

Ishiba pens letter to Xi as Japan aims to avoid trade crossfire

A high-level Japanese delegation will deliver a letter from Prime Minister Shigeru Ishiba to Chinese leader Xi Jinping this week, as Tokyo strives to avoid getting caught in the crossfire of escalating trade friction between China and the US.
Tetsuo Saito, the chief of the ruling party's junior coalition partner Komeito, will deliver the letter during a three-day visit from Tuesday to meet with Liu Jianchao, the head of the International Department of the Chinese Communist Party, among other dignitaries.
'The prime minister told me that he would like me to deliver a letter, as it may take some time before he can visit China,' Saito told reporters on Monday.
The gesture highlights Japan's desire to balance managing its relationships with China, its largest trading partner, and with the US, its sole formal security ally, as it proceeds with official trade negotiations with Washington seeking an exemption from sweeping tariffs imposed by President Donald Trump's administration earlier this month.
China, which accounts for about 20% of Japan's trade, has warned countries against cutting deals with the US that could undermine Beijing's interests. Bloomberg recently reported that Washington wants its allies to curb trade with China as part of negotiations over tariffs.
When asked about China's warning Tuesday, Japan's top government spokesperson Yoshimasa Hayashi didn't directly address the matter, instead saying that the tariff issue remains a top priority for the government.
Japan also has an array of bilateral disputes with China, including a continued ban by Beijing on seafood exports from Japan in response to Tokyo's release of wastewater from the wrecked Fukushima Dai-ichi Nuclear Power Plant into the ocean.
Japan and China agreed in 2024 to take steps toward restarting exports, but China is yet to officially reopen trade, saying that additional testing needs to be done. A second round of testing with China's participation took place last week.
Saito said that the issue of seafood and a separate ban on beef imports into China from Japan would likely be raised during his meetings, which he said would be about building trust.
'I hope to have a frank discussion about the concerns the Japanese people have toward China from a different perspective than governmental relations,' he said.
Saito deflected a question about the possibility of China making demands as trade negotiations between Japan and the US start, saying he will 'explain Japan's position on various issues,' without elaborating further.
The US has been pushing Japan for years to limit exports of machinery used to make semiconductors and other high-tech equipment.
Japan's Hayashi on Monday declined to comment on the contents of Ishiba's letter.
'It's necessary to increase areas of cooperation and coordination while resolving problems and matters of concern,' he said. –BLOOMBERG

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm
ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm

Malaysian Reserve

time2 hours ago

  • Malaysian Reserve

ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm

NEW YORK, June 6, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Registration Statement') issued in connection with Zenas BioPharma's September 2024 initial public offering ('IPO' or the 'Offering'), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Zenas BioPharma class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Zenas BioPharma action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@

Billion-dollar battery plant pauses construction in U.S. amid electric vehicle, tariff uncertainty
Billion-dollar battery plant pauses construction in U.S. amid electric vehicle, tariff uncertainty

The Star

time4 hours ago

  • The Star

Billion-dollar battery plant pauses construction in U.S. amid electric vehicle, tariff uncertainty

NEW YORK, June 6 (Xinhua) -- A Japanese company has halted construction on a 1.6 billion U.S. dollars factory in South Carolina to help make batteries for electric BMWs, citing "policy and market uncertainty," reported The Associated Press on Friday. "While Automotive Energy Supply Corp. (AESC) didn't specify what those problems are, South Carolina's Republican governor said the company is dealing with the potential loss of federal tax breaks for electric vehicle buyers and incentives for EV businesses as well as tariff uncertainties from President Donald Trump's administration," noted the report. "What we're doing is urging caution -- let things play out because all of the these changes are taking place," Governor Henry McMaster said. AESC announced the suspension in construction of its plant in Florence on Thursday. "Due to policy and market uncertainty, we are pausing construction at our South Carolina facility at this time," the company's statement said. AESC promised to restart construction, although it didn't say when, and vowed to meet its commitment to hire 1,600 workers and invest 1.6 billion dollars. The company said it has already invested 1 billion dollars in the Florence plant. The battery maker based in Japan also has facilities in China, the United Kingdom, France, Spain and Germany. In the United States, AESC has a plant in Tennessee and is building one in Kentucky. The statement didn't mention any changes with other plants.

US-China trade talks to resume in seven days: White House
US-China trade talks to resume in seven days: White House

New Straits Times

time5 hours ago

  • New Straits Times

US-China trade talks to resume in seven days: White House

WASHINGTON: Trade negotiations between US and Chinese officials are expected to resume within seven days, following a phone call between President Donald Trump and President Xi Jinping. The discussions will place particular emphasis on rare earth minerals, White House Trade Adviser Peter Navarro confirmed on Friday. "We expect that a meeting will take place within seven days," Navarro told reporters at the White House, commenting on the timeline of the next round of trade talks. Navarro stated that Trump has been clear that "the rare earth issue will be key to that negotiation", as reported by Sputnik/RIA Novosti. The US delegation will include Trade Representative Jamieson Greer, Treasury Secretary Scott Bessent, and Secretary of Commerce Howard Lutnick, according to Navarro. The advisor also mentioned that Thursday's call between Trump and Xi lasted approximately 90 minutes, during which both leaders demonstrated "a very clear understanding" of the expected outcomes of the upcoming discussions. Trump later shared on Truth Social that he had discussed "some of the intricacies" of the US-China trade deal with President Xi. He also announced that he had accepted Xi's invitation to visit China and extended a reciprocal invitation. Following high-level trade and economic talks in Geneva earlier in May, Washington and Beijing agreed to lower reciprocal tariffs by 115 percentage points each for 90 days. The US has reduced tariffs on Chinese goods from 145 per cent to 30 per cent, while China has cut tariffs on American imports from 125 per cent to 10 per cent. Later that month, Trump accused China of "totally violating" the Geneva agreement and remarked that "it is extremely hard" to reach a deal with Beijing.–BERNAMA

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store